Skip to content

Effect of Vitamin E on Microparticles in Transfusion-Dependent Thalassemia

Effect of Vitamin E on Changes of Microparticles in Pediatrics Patients with Transfusion-Dependent Thalassemia: A Double-Blind Randomized Placebo-Controlled Trials

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20220801001
Enrollment
70
Registered
2022-08-01
Start date
2022-07-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microparticle levels in transfusion-dependent thalassemia patients age more than 10 to 25 years. Microparticles in transfusion-dependent thalassemia, vitamin E in transfusion-dependent thalassemia, TDT, microparticles, vitamin E

Interventions

Once daily dose of vitamin E (400IU) given orally for the duration of 24 weeks,Once daily dose of placebo containing water and food coloring given orally for the duration of 24 weeks
Experimental Drug,Placebo Comparator Drug
Vitamin E ,Placebo

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 25 Years

Inclusion criteria

Inclusion criteria: 1. Severe beta-thalassemia, including beta-thalassemia major, beta-thalassemia/HbE , delta-beta-thalassemia, and severe alpha-thalassemia, including HbH with Hb Constant Spring (CS)/Pakse (PS), EF Bart's with Hb CS/PS, AE Bart's with CS/PS, who have followed up at the Hematology Clinic, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University 2. Transfusion-dependent (defined as the need of red cell transfusion of at least 7 transfusions/year) 3. Patients and/or guardians informed consents

Exclusion criteria

Exclusion criteria: 1. Not consent 2. History of vitamin E allergy 3. History of allergy to food coloring 4. History of bleeding disorders 5. Necessity of receiving other anti-oxidant agents, such as vitamin C or N-acetylcysteine

Design outcomes

Primary

MeasureTime frame
Numbers of red cell-, platelet- and endothelial-derived microparticles at 24 weeks after vitamin E supplementation Flow cytometry

Secondary

MeasureTime frame
Lipid peroxidation markers, such as malondialdehyde and glutathione peroxidase at 24 weeks after vitamin E supplementation ELISA,Vitamin E level at 24 weeks after vitamin E supplementation High-Performance liquid chromatography,Number of phosphatidyl serine-exposing red cells at 24 weeks after vitamin E supplementation Flow cytometry,Nitric oxide level at 24 weeks after vitamin E supplementation Nitric oxide analyzer,Hemolytic parameters, such as indirect bilirubinemia, reticulocyte count and lactate dehydrogenase at 24 weeks after vitamin E supplementation Routine chemical analysis

Countries

Thailand

Contacts

Public ContactDuantida Songdej

Faculty of Medicine Ramathibodi Hospital, Mahidol University

duantida.son@mahidol.ac.th022011749

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026